Protective role of epigallocatechin-3-gallate in health and disease: A perspective

Biomedicine and Pharmacotherapy

Volumn 78, Issue , 2016, Pages 50-59

  Chowdhury, Animesh ^a   Sarkar, Jaganmay ^a   Chakraborti, Tapati ^a   Pramanik, Pijush Kanti ^a   Chakraborti, Sajal ^a  

^a UNIVERSITY OF KALYANI   (India)

Author keywords

Cancer; Cardiovascular diseases; Diabetes; EGCG; Neurodegenerative diseases

Indexed keywords

EPIGALLOCATECHIN GALLATE; CATECHIN; PROTECTIVE AGENT;

BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CHEMICAL COMPOSITION; DEGENERATIVE DISEASE; DIABETES MELLITUS; DRUG ACTIVITY; DRUG MECHANISM; HUMAN; LUNG DISEASE; MOLECULAR DYNAMICS; NEOPLASM; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; TEA; ANALOGS AND DERIVATIVES; ANIMAL; BIOLOGICAL MODEL; DISEASES; HEALTH;

ANIMALS; CATECHIN; DISEASE; HEALTH; HUMANS; MODELS, BIOLOGICAL; PROTECTIVE AGENTS;

EID: 84958645581     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2015.12.013     Document Type: Review

References (140)

1. Kuroda Y., Hara Y. Antimutagenic and anticarcinogenic activity of tea polyphenols. Mutat. Res. 1999, 436:69-97.
2. Graham H.N. Green tea composition, consumption and polyphenol chemistry. Prev. Med. 1992, 21:334-350.
3. Langley-Evans S.C. Antioxidant potential of green and black tea determined using the ferric reducing power assay (FRAP). Int. J. Food Sci. Nutr. 2000, 51:181-188.
4. McKay D.L., Blumberg J.B. The role of tea in human health: An update. J. Am. Coll. Nutr. 2002, 21:1-13.
5. Kavanagh K.T., Hafer L.J., Kim D.W., Mann K.K., Sherr D.H., Rogers A.E., Sonenshein G.E. Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. J. Cell. Biochem. 2001, 82:387-398.
6. Sueoka N., Suganuma M., Sueoka E., Okabe S., Matsuyama S., Imai K., Nakachi K., Fujiki H. A new function of green tea: prevention of life style related diseases. Ann. N.Y. Acad. Sci. 2001, 928:274-280.
7. Dona M., Dell'Aica I., Calabrese F., Benelli R., Morini M., Albini A., Garbisa S. Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis. J. Immunol. 2003, 170:4335-4341.
8. Haqqi T.M., Anthony D.D., Gupta S., Ahmad N., Lee M.S., Kumar G.K., Mukhtar H. Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:4524-4529.
9. Sudano A.R., Blanco A.R., Giuliano F., Rusciano D., Enea V. Epigallocatechin-gallate enhances the activity of tetracycline in staphylococci by inhibiting its efflux from bacterial cells. Antimicrob. Agents Chemother. 2004, 48:1968-1973.
10. Sartippour M.R., Shao Z.M., Heber D., Beatty P., Zhang L., Liu C., Ellis L., Liu W., Go V.L., Brooks M.N. Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells. J. Nutr. 2002, 132:2307-2311.
11. Osada K., Takahashi M., Hoshina S., Nakamura M., Nakamura S., Sugano M. Tea catechins inhibit cholesterol oxidation accompanying oxidation of low density lipoprotein in vitro. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2001, 128:153-164.
12. Weber J.M., Ruzindana-Umunyana A., Imbeault L., Sircar S. Inhibition of adenovirus infection and adenain by green tea catechins. Antiviral Res. 2003, 58:167-173.
13. Weinreb O., Mandel S., Amit T., Youdim M.B.H. Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases. J. Nutr. Biochem. 2004, 15:506-516.
14. Raederstorff D.G., Schlachter M.F., Elste V., Weber P. Effect of EGCG on lipid absorption and plasma lipid levels in rats. J. Nutr. Biochem. 2003, 14:326-332.
15. Mukhtar H., Ahmad N. Tea polyphenols: prevention of cancer and optimizing health. Am. J. Clin. Nutr. 2000, 71:1698-1704.
16. Riemersma R.A., Rice-Evans C.A., Tyrrell R.M., Clifford M.N., Lean M.E. Tea flavonoids and cardiovascular health. Q. J. Med. 2001, 94:277-282.
17. Vinson J.A. Black and green tea and heart disease: a review. Biofactors 2000, 13:127-132.
18. Sano M., Tabata M., Suzuki M., Degawa M., Miyase T., Maeda-Yamamoto M. Simultaneous deermination of twelve tea catechins by highperformance liquid chromatography with electrochemical detection. Analyst 2001, 126:816-820.
19. Higdon J.V., Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit. Rev. Food Sci. Nutr. 2003, 43:89-143.
20. Vanessa C., Gary W. A Review of the health effects of green tea catechins in in vivo animal models. J Nutr. 2004, 134:3431-3440.
21. Babu P.V., Sabitha K.E., Shyamaladevi C.S. Therapeutic effect of green tea extract on oxidative stress in aorta and heart of streptozotocin diabetic rats. Chem. Biol. Interact. 2006, 162:114-120.
22. Unno K., Takabayashi F., Yoshida H., Choba D., Fukutomi R., Kikunaga N., Kishido T., Oku N., Hoshino M. Daily consumption of green tea catechin delays memory regression in aged mice. Biogerontology 2007, 8:89-95.
23. Roomi M.W., Ivanov V., Kalinovsky T., Niedzwiecki A., RathIn M. In vitro and in vivo antitumorigenic activity of a mixture of lysine proline, ascorbic acid, and green tea extract on human breast cancer lines MDA-MB-231 and MCF-7. Med. Oncol. 2007, 22:129-138.
24. Khokhar S., Magnusdottir S.G. Total phenol, catechin, and caffeine contents of teas commonly consumed in the United Kingdom. J. Agric. Food Chem. 2002, 50:565-570.
25. Fernandez P.L., Martin M.J., Gonzalez A.G., Pablos F. HPLC determination of catechins and caffeine in tea. Differentiation of green, black and instant teas. Analyst 2000, 125:421-425.
26. Chen Z.Y., Zhu Q.Y., Tsang D., Huang Y. Degradation of green tea catechins in tea drinks. J. Agr. Food Chem. 2001, 49:477-482.
27. Chen Z.Y., Zhu Q.Y., Wong Y.F., Zhang Z., Chung H.Y. Stabilizing effect of ascorbic acid on green tea catechins. J. Agr. Food Chem. 1998, 46:2512-2516.
28. Mandel S., Weinreb O., Amit T., Youdim M.B. Cell signaling pathways in the neuroprotective actions of the green tea polyphenol(-)-epigallocatechin- 3-gallate: implications for neurodegenerative diseases. J. Neurochem. 2004, 88:1555-1569.
29. Moyers S.B., Kumar N.B. Green tea polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials. Nutr. Rev. 2004, 62:204-211.
30. Kao Y.H., Chang H.H., Lee M.J., Chen C.L. Tea, obesity, and diabetes. Mol. Nutr. Food Res. 2006, 50:188-210.
31. Shoji Y., Nakashima H. Glucose-lowering effect of powder formulation of African black tea extract in KK-A(y)/TaJcl diabetic mouse. Arch. Pharmacol. Res. 2006, 29:786-794.
32. Chacko S.M., Thambi P.T., Kuttan R., Nishigaki I. Beneficial effects of green tea: a literature review. Chin. Med. 2010, 5:13.
33. Klaus S., Pultz S., Thone-Reineke C., Wolfram S. Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. Int. J. Obes. 2005, 29:615-623.
34. Wolfram S., Raederstorff D., Preller M., Wang Y., Teixeira S.R., Riegger C., Weber P. Epigallocatechin gallate supplementation alleviates diabetes in rodentsm. J. Nutr. 2006, 136:2512-2518.
35. Ortsäter H., Grankvist N., Wolfram S., Kuehn N., Sjöholm A. Diet supplementation with green tea extract epigallocatechin gallate prevents progression to glucose intolerance in db/db mice. Nutr. Metab. 2012, 9:11.
36. Yamabe N., Yokozawa T., Oya T., Kim M. Therapeutic potential of (-)-epigallocatechin 3-O-gallate on renal damage in diabetic nephropathy model rats. J. Pharmacol. Exp. Ther. 2006, 319:228-236.
37. Waltner-Law M.E., Wang X.L., Law B.K., Hall R.K., Nawano M. Granner DK Epigallocatecin gallate a constituent of green tea, represses hepatic glucose production. J. Biol. Chem. 2002, 277:34933-34940.
38. Tsuneki H., Ishizuka M., Terasawa M., Wu J.B., Sasaoka T., Kimura I. Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. BMC Pharmacol. 2004, 4:18-21.
39. Wu L.Y., Juan C.C., Hwang L.S., Hsu Y.P., Ho P.H., Ho L.T. Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model. Eur. J. Nutr. 2004, 43:116-124.
40. Han M.K. Epigallocatechin gallate, a constituent of green tea, suppresses cytokine-induced pancreatic beta-cell damage. Exp. Mol. Med. 2003, 35:136-139.
41. Song E.K., Hur H., Han M.K. Epigallocatechin gallate prevents autoimmune diabetes induced by multiple low doses of streptozotocin in mice. Arch. Pharm. Res. 2003, 26:559-563.
42. Lambert J.D., Lee M.J., Lu H., Meng X., Hong J.J.J., Seril D.N., Sturgill M.G., Yang C.S. Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice. J. Nutr. 2003, 133:4172-4177.
43. Ullmann U., Haller J., Decourt J.P., Girault N., Girault J., Richard-Caudron A.S., Pineau B., Weber P. A single ascending dose study of epigallocatechin gallate in healthy volunteers. J. Int. Med. Res. 2003, 31:88-101.
44. Hung P.F., Wu B.T., Chen H.C., Chen Y.H., Chen C.L., Wu M.H., Liu H.C., Lee M.J., Kao Y.H. Antimitogenic effect of green tea (-)-epigallocatechin gallate on 3T3-L1 preadipocytes depends on the ERK and Cdk2 pathways. Am. J. Physiol. Cell Physiol. 2005, 288:1094-1108.
45. Wu B.T., Hung P.F., Chen H.C., Huang R.N., Chang H.H., Kao Y.H. The apoptotic effect of green tea (-)-epigallocatechin gallateon 3T3-L1 preadipocytes depends on the Cdk2 pathway. J. Agric. Food Chem. 2005, 53:5695-5701.
46. Wang C.T., Chang H.H., Hsiao C.H., Lee M.J., Ku H.C., Hu Y.J., Kao Y.H. The effects of green tea (-)-epigallocatechin-3-gallate on reactive oxygen species in 3T3-L1 preadipocytes and adipocytes depend on the glutathione and 67kDa laminin receptor pathways. Mol. Nutr. Food Res. 2009, 53:349-360.
47. Mukai K., Nagai S., Ohara K. Kinetic study of the quenchingreaction of singlet oxygen by tea catechins in ethanolsolution. Free Radic. Biol. Med. 2005, 39:752-761.
48. Kobayashi Y., Suzuki M., Satsu H., Arai S., Hara Y., Suzuki K., Miyamoto Y., Shimizu M. Green tea polyphenols inhibit the sodium-dependent glucose transporter of intestinal epithelial cells by a competitive mechanism. J. Agric. Food Chem. 2000, 48:5618-5623.
49. Yang Q., Graham T.E., Mody N., Preitner F., Peroni O.D., Zabolotny J.M., Kotani K., Quadro L., Kahn B.B. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005, 436:356-362.
50. Herman M.A., Kahn B.B. Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony. J. Clin. Invest. 2006, 116:1767-1775.
51. Park J.H., Bae J.H., Im S.S., Song D.K. Green tea and type 2 diabetes. Integr. Med. Res. 2014, 3:4-10.
52. Artali R., Beretta G., Morazzoni P., Bombardelli E., Meneghetti F. Green tea catechins in chemoprevention of cancer: a molecular docking investigation into their interaction with glutathione S-transferase (GST P1-1). J. Enzyme Inhib. Med. Chem. 2009, 24:287-295.
53. Mann C.D., Neal C.P., Garcea G., Manson M.M., Dennison A.R., Berry D.P. Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis. Eur. J. Cancer Prev. 2009, 18:13-25.
54. Kuo Y.C., Yu C.L., Liu C.Y., Wang S.F., Pan P.C., Wu M.T., Ho C.K., Lo Y.S., Li Y., Christiani D.C. A population-based, case-control study of green tea consumption and leukemia risk in southwestern Taiwan. Cancer Causes Control 2009, 20:57-65.
55. Chen D., Milacic V., Chen M.S., Wan S.B., Lam W.H., Huo C., Landis-Piwowar K.R., Cui Q.C., Wali A., Chan T.H., Dou Q.P. Tea polyphenols, their biological effects and potential molecular targets. Histol. Histopathol. 2008, 23:487-496.
56. Steevens J., Schouten L.J., Verhage B.A., Goldbohm R.A., van den Brandt P.A. Tea and coffee drinking and ovarian cancer risk: results from the Netherlands cohort study and a meta-analysis. Br. J. Cancer 2007, 97:1291-1294.
57. Kurahashi N., Sasazuki S., Iwasaki M., Inoue M., Tsugane S. Green tea consumption and prostate cancer risk in Japanese men: a prospective study. Am. J. Epidemiol. 2008, 167:71-77.
58. Syed D.N., Khan N., Afaq F., Mukhtar H. Chemoprevention of prostate cancer through dietary agents: progress and promise. Cancer Epidemiol. Biomarkers Prev. 2007, 16:2193-2203.
59. Liang W., Binns C.W., Jian L., Lee A.H. Does the consumption of green tea reduce the risk of lung cancer among smokers?. Evid. Based Complement. Alternat. Med. 2007, 4:17-22.
60. Ju J., Hong J., Zhou J.N., Pan Z., Bose M., Liao J., Yang G.Y., Liu Y.Y., Hou Z., Lin Y., Ma J., Shih W.J., Carothers A.M., Yang C.S. Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (-)-pigallocatechin-3-gallate, the major catechin in green tea. Cancer. Res. 2005, 65:10623-10631.
61. Shimizu M., Deguchi A., Hara Y., Moriwaki H., Weinstein I.B. EGCG inhibits activation of the insulin-like growth factor-receptor in human colon cancer cells. Biochem. Biophys. Res. Commun. 2005, 334:947-953.
62. Yang C.S., Wang X., Lu G., Picinich S.C. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat. Rev. Cancer 2009, 9:429-439.
63. Yang C.S., Wang H., Li G.X., Yang Z., Guan F., Jin H. Cancer prevention by tea: Evidence from laboratory studies. Pharmacol. Res. 2011, 64:113-122.
64. Sun C.L., Yuan J.M., Koh W.P., Yu M.C. Green tea, black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies. Carcinogenesis 2006, 27:1301-1309.
65. Bettuzzi S., Brausi M., Rizzi F., Castagnetti G., Peracchia G., Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res. 2006, 66:1234-1240.
66. Farabegoli F., Barbi C., Lambertini E., Piva R. (-)-Epigallocatechin-3-gallate downregulates estrogen receptor alpha function in MCF-breast carcinoma cells. Cancer Detect. Prev. 2007, 31:499-504.
67. Thangapazham R.L., Passi N., Maheshwari R.K. Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast cancer cells. Cancer Biol. Ther. 2007, 6:1938-1943.
68. Shankar S., Ganapathy S., Hingorani S.R., Srivastava R.K. EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Front. Biosci. 2008, 13:440-452.
69. Ho Y.C., Yang S.F., Peng C.Y., Chou M.Y., Chang Y.C. Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator. J. Oral Pathol. Med. 2007, 36:588-593.
70. Kim M., Murakami A., Ohigashi H. Modifying effects of dietary factors on (-)-epigallocatechin-3-gallate-induced pro-matrix metalloproteinase-production in HT-29 human colorectal cancer cells. Biosci. Biotechnol. Biochem. 2007, 71:2442-2450.
71. Siddiqui I.A., Malik A., Adhami V.M., Asim M., Hafeez B.B., Sarfaraz S., Mukhtar H. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated poptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene 2008, 27:2055-2063.
72. Yu H.N., Shen S.R., Yin J.J. Effects of metal ions, catechins, and their interactions on prostate cancer. Crit. Rev. Food Sci. Nutr. 2007, 47:711-719.
73. Khan N., Mukhtar H. Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett. 2008, 269:269-280.
74. Yamamoto T., Hsu S., Lewis J., Wataha J., Dickinson D., Singh B., Bollag W.B., Lockwood P., Ueta E., Osaki T., Schuster G. Green tea polyphenols causes differential oxidative environments in tumor versus normal epithelial cells. J. Pharmacol. Exp. Ther. 2003, 301:230-236.
75. Nakachi K., Matsuyama S., Miyake S., Suganuma M., Imai K. Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. Biofactors 2000, 13:49-54.
76. Inoue M., Tajima K., Mizutani M., Iwata H., Iwase T., Miura S., Hirose K., Hamajima N., Tomonaga S. Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the hospital-based epidemiologic research program at Aichi cancer center (HERPACC), Japan. Cancer Lett. 2001, 167:175-182.
77. Chung S.S., Vadgama J.V. Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NFκB signaling. Anticancer Res. 2015, 35:39-46.
78. Wang S., Chen R., Zhong Z., Shi Z., Chen M., Wang Y. Epigallocatechin-3-gallate potentiates the effect of curcumin in inducing growth inhibition and apoptosis of resistant breast cancer cells. Am. J. Chin. Med. 2014, 42:1279-1300.
79. Luo H.Q., Xu M., Zhong W.T., Cui Z.Y., Liu F.M., Zhou K.Y., Li X.Y. EGCG decreases the expression of HIF-1α and VEGF and cell growth in MCF-breast cancer cells. J. BUON 2014, 19:435-439.
80. Braicu C., Gherman C.D., Irimie A., Berindan-Neagoe I. Epigallocatechin-3-Gallate (EGCG) inhibits cell proliferation and migratory behaviour of triple negative breast cancer cells. J. Nanosci. Nanotechnol. 2013, 13:632-637.
81. Awad A.B., Barta S.L., Fink C.S., Bradford P.G. Beta-sitosterol enhances tamoxifen effectiveness on breast cancer cells by affecting ceramide metabolism. Mol. Nutr. Food Res. 2008, 52:419-426.
82. Huang H.C., Way T.D., Lin C.L., Lin J.K. EGCG stabilizes p27kip1 in E2-stimulated MCF-cells through down-regulation of the Skp2 protein. Endocrinology 2008, 149:5972-5983.
83. Zhou J.R., Yu L.Y., Mai Z.M., Blackburn G.L. Combined inhibition of estrogendependent human breast carcinoma by soy and tea bioactive components in mice. Int. J. Cancer 2004, 108:8-14.
84. Kanwar J., Taskeen M., Mohammad I., Huo C., Chan T.H., Dou Q.P. Recent advances on tea polyphenols. Front. Biosci (Elite Ed). 2012, 4:111-131.
85. Komori A., Yatsunami J., Okabe S., Abe S., Hara K., Suganuma M., Kim S.J., Fujiki H. Anticarcinogenic activity of green tea polyphenols. Jpn. J. Clin. Oncol. 1993, 23:186-190.
86. Cromie M.M., Gao W. Epigallocatechin-3-gallate enhances the therapeutic effects of leptomycin B on human lung cancer a549 cells. Oxid. Med. Cell. Longev 2015, 2015:217304.
87. Shi J., Liu F., Zhang W., Liu X., Lin B., Tang X. Epigallocatechin-3-gallate inhibits nicotine-induced migration and invasion by the suppression of angiogenesis and epithelial-mesenchymal transition in non-small cell lung cancer cells. Oncol. Rep. 2015, 33:2972-2980.
88. Sonoda J.I., Ikeda R., Baba Y., Narumi K., Kawachi A., Tomishige E., Nishihara K., Takeda Y., Yamada K., Sato K., Motoya T. Green tea catechin, epigallocatechin-3-gallate, attenuates the cell viability of human non-small-cell lung cancer A549 cells via reducing Bcl-xL expression. Exp. Ther. Med. 2014, 8:59-63.
89. Kim K.C., Lee C. Reversal of cisplatin resistance by epigallocatechin gallate is mediated by downregulation of axl and tyro 3 expressions in human lung cancer cells. Korean J. Physiol. Pharmacol. 2014, 18:61-66.
90. Shim J.H., Su Z.Y., Chae J.I., Kim D.J., Zhu F., Ma W.Y., Bode A.M., Yang C.S., Dong Z. Epigallocatechin gallate suppresses lung cancer cell growth through Ras-GTPase-activating protein SH3 domain-binding protein 1. Cancer Prev. Res. 2010, 3:670-679.
91. Ma Y.C., Li C., Gao F., Xu Y., Jiang Z.B., Liu J.X., Jin L.Y. Epigallocatechin gallate inhibits the growth of human lung cancer by directly targeting the EGFR signaling pathway. Oncol. Rep. 2014, 31:1343-1349.
92. Sakamoto Y., Terashita N., Muraguchi T., Fukusato T., Kubota S. Effects of epigallocatechin-3-gallate (EGCG) on A549 lung cancer tumor growth and angiogenesis. Biosci. Biotechnol. Biochem. 2013, 77:1799-1803.
93. Li X., Feng Y., Liu J., Feng X., Zhou K., Tang X. Epigallocatechin-3-gallate inhibits IGF-I-stimulated lung cancer angiogenesis through downregulation of HIF-1α and VEGF expression. J. Nutrigenet. Nutrigenomics 2013, 6:169-178.
94. Jin L., Li C., Xu Y., Wang L., Liu J., Wang D., Hong C., Jiang Z., Ma Y., Chen Q., Yu F. Epigallocatechin gallate promotes p53 accumulation and activity via the inhibition of MDM2-mediated p53 ubiquitination in human lung cancer cells. Oncol. Rep. 2013, 29:1983-1990.
95. Ko H., So Y., Jeon H., Jeong M.H., Choi H.K., Ryu S.H., Lee S.W., Yoon H.G., Choi K.C. TGF-β1-induced epithelial-mesenchymal transition and acetylation of Smad2 and Smad3 are negatively regulated by EGCG in human A549 lung cancer cells. Cancer Lett. 2013, 335:205-213.
96. Deng Y.T., Lin J.K. EGCG inhibits the invasion of highly invasive CL1-lung cancer cells through suppressing MMP-expression via JNK signaling and induces G2/M arrest. J. Agric. Food Chem. 2011, 59:13318-13327.
97. Gupta S., Hastak K., Ahmad N., Lewin J.S., Mukhtar H. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:10350-10355.
98. Adhami V.M., Siddiqui I.A., Ahmad N., Gupta S., Mukhtar H. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res. 2004, 64:8715-8722.
99. Paschka A.G., Butler R., Young C.Y. Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate. Cancer Lett. 1998, 130:1-7.
100. Brusselmans K., De S.E., Heyns W., Verhoeven G., Swinnen J.V. Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells. Int. J. Cancer 2003, 106:856-862.
101. Katiyar S.K., Agarwal R., Wang Z.Y., Bhatia A.K., Mukhtar H. (-)-Epigallocatechin-3-gallate in Camellia sinensis leaves from himalayan region of Sikkim: inhibitory effects against biochemical events and tumor initiation in SENCAR mouse skin. Nutr. Cancer 1992, 18:73-83.
102. Peters U., Poole C., Arab L. Does tea affect cardiovascular disease? A meta-analysis. Am. J. Epidemiol. 2001, 154:495-503.
103. Tijburg L.B.M., Mattern T., Folts J.D., Weisgerber U.M., Katan M.B. Tea flavonoids and cardiovascular diseases: a review. Food Sci. Nutr. 1997, 37:771-785.
104. Young W., Hotovec R.L., Romero A.G. Tea and atherosclerosis. Nature 1967, 216:1015-1016.
105. Fu-quing L., Mei-fang Z., Xiao-gang Z., Ji-min L., Wei-long Y. A study on tea-pigment in prevention of atherosclerosis. Chin. Med. J. 1989, 102:579-583.
106. Tijburg L.B.M., Wiseman S.A., Meijer G.W., Weststrate J.A. Effects of green tea, black tea and dietary lipophilic antioxidants on LDL oxidizability and atherosclerosis in hypercholesterolemic rabbits. Atherosclerosis 1997, 135:37-47.
107. Hong Z., Xu Y., Yin J.F., Jin J., Jiang Y., Du Q. Improving the effectiveness of (-)-epigallocatechin gallate (EGCG) against rabbit atherosclerosis by EGCG-loaded nanoparticles prepared from chitosan and polyaspartic acid. J. Agric. Food Chem. 2014, 62:12603-12609.
108. Cai Y., Kurita-Ochiai T., Hashizume T., Yamamoto M. Green tea epigallocatechin-3-gallate attenuates Porphyromonas gingivalis-induced atherosclerosis. Pathog. Dis. 2013, 67:76-83.
109. Ramesh E., Elanchezhian R., Sakthivel M., Jayakumar T., Senthil Kumar R.S., Geraldine P., Thomas P.A. Epigallocatechin gallate improves serum lipid profile and erythrocyte and cardiac tissue antioxidant parameters in Wistar rats fed an atherogenic diet. Fundam. Clin. Pharmacol. 2008, 22:275-284.
110. Ramesh E., Geraldine P., Thomas P.A. Regulatory effect of epigallocatechin gallate on the expression of C-reactive protein and other inflammatory markers in an experimental model of atherosclerosis. Chem. Biol. Interact. 2010, 183:125-132.
111. Chyu K.Y., Babbidge S.M., Zhao X., Dandillaya R., Rietveld A.G., Yano J., Dimayuga P., Cercek B., Shah P.K. Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice. Circulation 2004, 109:2448-2453.
112. Wolfram S. Effects of green tea and EGCG on cardiovascular and metabolic health. J. Am. Coll. Nutr. 2007, 26:373-388.
113. Hotta Y., Huang L., Muto T., Yajima M., Miyazeki K., Ishikawa N., Fukuzawa Y., Wakida Y., Tushima H., Ando H., Nonogaki T. Positive inotropic effect of purified green tea catechin derivative in guinea pig hearts: the measurements of cellular Ca2and nitric oxide release. Eur. J. Pharmacol. 2006, 552:123-130.
114. Aneja R., Hake P.W., Burroughs T.J., Denenberg A.G., Wong H.R., Zingarelli B. Epigallocatechin a green tea polyphenol, attenuates myocardial ischemia reperfusion injury in rats. Mol. Med. 2004, 10:55-62.
115. Li H.L., Huang Y., Zhang C.N., Liu G., Wei Y.S., Wang A.B., Liu Y.Q., Hui R.T., Wei C., Williams G.M., Liu D.P., Liang C.C. Epigallocathechin- 3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways. Free Radic. Biol. Med. 2006, 40:1756-1775.
116. Zeng X., Tan X. Epigallocatechin-3-gallate and zinc provide anti-apoptotic protection against hypoxia/reoxygenation injury in H9c2 rat cardiac myoblast cells. Mol. Med. Rep. 2015, 12:1850-1856.
117. Widlansky M.E., Hamburg N.M., Anter E., Holbrook M., Kahn D.F., Elliott J.G., Keaney J.F., Vita J.A. Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease. J. Am. Coll. Nutr. 2007, 26:95-102.
118. Yao C., Zhang J., Liu G., Chen F., Lin Y. Neuroprotection by (-)-epigallocatechin-3-gallate in a rat model of stroke is mediated through inhibition of endoplasmic reticulum stress. Mol. Med. Rep. 2014, 9:69-76.
119. Ding J., Fu G., Zhao Y., Cheng Z., Chen Y., Zhao B., He W., Guo L.J. EGCG ameliorates the suppression of long-term potentiation induced by ischemia at the Schaffer collateral-CA1 synapse in the rat. Cell. Mol. Neurobiol. 2012, 32:267-277.
120. Lim S.H., Kim H.S., Kim Y.K., Kim T.M., Im S., Chung M.E., Hong B.Y., Ko Y.J., Kim H.W., Lee J.I. The functional effect of epigallocatechin gallate on ischemic stroke in rats. Acta Neurobiol. Exp. 2010, 70:40-46.
121. Haque A.M., Hashimoto M., Katakura M., Hara Y., Shido O. Green tea catechins prevent cognitive deficits caused by Abeta1-40 in rats. J. Nutr. Biochem. 2008, 19:619-626.
122. Suzuki M., Tabuchi M., Ikeda M., Umegaki K., Tomita T. Protective effects of green tea catechins on cerebral ischemic damage. Med. Sci. Monit. 2004, 10:166-174.
123. Uchida S., Ozaki M., Akashi T., Yamashita K., Niwa M., Taniyama K. Effects of (-)-epigallocatechin-3-O-gallate (green tea tannin) on the life span of stroke-prone spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 1995, 22:302-313.
124. Giakoustidis A.E., Giakoustidis D.E., Iliadis S., Papageorgiou G., Koliakou K., Kontos N., Taitzoglou I., Botsoglou E., Papanikolaou V., Atmatzidis K., Takoudas D., Antoniadis A. Attenuation of intestinal ischemia/reperfusion induced liver and lung injury by intraperitoneal administration of (-)-epigallocatechin-3-gallate. Free Radic. Res. 2006, 40:103-110.
125. Liu W., Dong M., Bo L., Li C., Liu Q., Li Y., Ma L., Xie Y., Fu E., Mu D., Pan L., Jin F., Li Z. Epigallocatechin-3-gallate ameliorates seawater aspiration-induced acute lung injury via regulating inflammatory cytokines and inhibiting JAK/STAT1 pathway in rats. Mediators Inflamm. 2014, 2014:612593.
126. Ritchie K., Lovestone S. The dementias. Lancet 2002, 360:1759-1766.
127. Kuriyama S., Hozawa A., Ohmori K., Shimazu T., Matsui T., Ebihara S., Awata S., Nagatomi R., Arai H., Tsuji I. Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project 1. Am. J. Clin. Nutr. 2006, 83:355-361.
128. He M., Liu M.Y., Wang S., Tang Q.S., Yao W.F., Zhao H.S., Wei M.J. Research on EGCG improving the degenerative changes of the brain in AD model mice induced with chemical drugs. Zhong. Yao. Cai. 2012, 35:1641-1644.
129. Sommer A.P., Bieschke J., Friedrich R.P., Zhu D., Wanker E.E., Fecht H.J., Mereles D., Hunstein W. 670 nm laser light and EGCG complementarily reduce amyloid-β aggregates in human neuroblastoma cells: basis for treatment of Alzheimer's disease?. Photomed. Laser Surg. 2012, 30:54-60.
130. Fernandez J.W., Rezai-Zadeh K., Obregon D., Tan J. EGCG functions through estrogen receptor-mediated activation of ADAM10 in the promotion of non-amyloidogenic processing of APP. FEBS Lett. 2010, 584:4259-4267.
131. Lee J.W., Lee Y.K., Ban J.O., Ha T.Y., Yun Y.P., Han S.B., Oh K.W., Hong J.T. Green tea (-)-epigallocatechin-3-gallate inhibits beta-amyloid-induced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-kappaB pathways in mice. J. Nutr. 2009, 139:1987-1993.
132. Lee Y.K., Yuk D.Y., Lee J.W., Lee S.Y., Ha T.Y., Oh K.W., Yun Y.P., Hong J.T. (-)-Epigallocatechin-3-gallate prevents lipopolysaccharide-induced elevation of beta-amyloid generation and memory deficiency. Brain Res. 2009, 1250:164-174.
133. Obregon D.F., Rezai-Zadeh K., Bai Y., Sun N., Hou H., Ehrhart J., Zeng J., Mori T., Arendash G.W., Shytle D., Town T., Tan J. ADAM10 activation is required for green tea (-)- epigallocatechin-3-gallate-induced alpha-secretase cleavage of amyloid precursor protein. J. Biol. Chem. 2006, 281:16419-16427.
134. Rezai-Zadeh K., Shytle D., Sun N., Mori T., Hou H., Jeanniton D., Ehrhart J., Townsend K., Zeng J., Morgan D., Hardy J., Town T., Tan J. Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J. Neurosci. 2005, 25:8807-8814.
135. Rezai-Zadeh K., Arendash G.W., Hou H., Fernandez F., Jensen M., Runfeldt M., Shytle R.D., Tan J. Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain Res. 2008, 1214:177-187.
136. Checkoway H., Powers K., Smith-Weller T., Franklin G.M., Longstreth W.T., Swanson P.D. Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am. J. Epidemiol. 2002, 155:732-738.
137. Hu G., Bidel S., Jousilahti P., Antikainen R., Tuomilehto J. Coffee and tea consumption and the risk of Parkinson's disease. Mov. Disord. 2007, 22:2242-2248.
138. Lorenzen N., Nielsen S.B., Yoshimura Y., Vad B.S., Andersen C.B., Betzer C., Kaspersen J.D., Christiansen G., Pedersen J.S., Jensen P.H., Mulder F.A., Otzen D.E. How epigallocatechin gallate can inhibit α-synuclein oligomer toxicity in vitro. J. Biol. Chem. 2014, 289:21299-21310.
139. Chao J., Lau W.K., Huie M.J., Ho Y.S., Yu M.S., Lai C.S., Wang M., Yuen W.H., Lam W.H., Chan T.H., Chang R.C. A pro-drug of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) prevents differentiated SH-SY5Y cells from toxicity induced by 6-hydroxydopamine. Neurosci. Lett. 2010, 469:360-364.
140. Choi J.Y., Park C.S., Kim D.J., Cho M.H., Jin B.K., Pie J.E., Chung W.G. Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate. Neurotoxicology 2002, 23:367-374.